CGB 0.00% 2.1¢ cann global limited

The research is on the use of cannabinoids for treating multiple...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,283 Posts.
    lightbulb Created with Sketch. 1487
    The research is on the use of cannabinoids for treating multiple sclerosis and other auto-immune diseases.
    This article reports the MCL funding and gives a surprisingly specific description of Prof. Meiri’s strategy.

    Unique Cannabinoid Profile May Help Control Autoimmune Dysfunction in Multiple Sclerosis
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.